Dianthus Therapeutics, Inc. /DE/ - DNTH
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 6.0% | 2,611,733 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 6.0% | 2,611,733 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Rajeev Shah | 6.0% | 2,611,733 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 6.0% | 2,611,733 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 6.9% | 2,981,674 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 6.9% | 2,981,674 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 6.9% | 2,981,674 | View |
| Nov 25, 2025 | SCHEDULE 13D/A | — | 9.99% | — | View |
| Nov 19, 2025 | SCHEDULE 13D/A | — | 5.0% | 42,876,015 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Capital, LP | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | David Kroin | 0.0% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Octagon Capital Advisors LP | 6.1% | 2,416,667 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Octagon Investments Master Fund LP | 5.3% | 2,125,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Octagon Private Opportunities Fund II LP | 0.7% | 291,667 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ting Jia | 6.1% | 2,416,667 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Vestal Point Capital, LP | 3.0% | 1,180,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ryan Wilder | 3.0% | 1,180,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | BCLS Fund III Investments, LP | 3.1% | 1,315,892 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.5% | 3,866,733 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Peter Kolchinsky | 9.5% | 3,866,733 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Rajeev Shah | 9.5% | 3,866,733 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.5% | 3,866,733 | View |
| Nov 12, 2025 | SCHEDULE 13G | Wellington Management Group LLP | 6.5% | 2,577,662 | View |
| Nov 12, 2025 | SCHEDULE 13G | Wellington Group Holdings LLP | 6.5% | 2,577,662 | View |
| Nov 12, 2025 | SCHEDULE 13G | Wellington Investment Advisors Holdings LLP | 6.5% | 2,577,662 | View |
| Nov 12, 2025 | SCHEDULE 13G | Wellington Management Company LLP | 6.3% | 2,577,662 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | FMR LLC | 15.0% | 5,970,638 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 15.0% | 5,970,638 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.